147 related articles for article (PubMed ID: 1389099)
21. Progesterone receptor expression in meningiomas.
Carroll RS; Glowacka D; Dashner K; Black PM
Cancer Res; 1993 Mar; 53(6):1312-6. PubMed ID: 8443810
[TBL] [Abstract][Full Text] [Related]
22. Epidermal Growth Factor Receptor and its Oncogenic
Kielbus M; Rola R; Jarosz B; Jeleniewicz W; Cybulski M; Stenzel-Bembenek A; Podkowinski A; Smok-Kalwat J; Polberg K; Trojanowski T; Stefaniuk D; Stepulak A
Anticancer Res; 2021 Feb; 41(2):983-991. PubMed ID: 33517305
[TBL] [Abstract][Full Text] [Related]
23. Expression of hypoxia inducible factor-1 alpha and correlation with preoperative embolization of meningiomas.
Jensen RL; Soleau S; Bhayani MK; Christiansen D
J Neurosurg; 2002 Sep; 97(3):658-67. PubMed ID: 12296651
[TBL] [Abstract][Full Text] [Related]
24. Epidermal growth factor receptor expression in human gliomas.
Torp SH; Helseth E; Dalen A; Unsgaard G
Cancer Immunol Immunother; 1991; 33(1):61-4. PubMed ID: 2021959
[TBL] [Abstract][Full Text] [Related]
25. Characterization of insulin-like growth factor I and epidermal growth factor receptors in meningioma.
Kurihara M; Tokunaga Y; Tsutsumi K; Kawaguchi T; Shigematsu K; Niwa M; Mori K
J Neurosurg; 1989 Oct; 71(4):538-44. PubMed ID: 2552046
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of insulin-like growth factor II in human meningiomas.
Lichtor T; Kurpakus MA; Gurney ME
Neurosurgery; 1991 Sep; 29(3):405-9; discussion 409-10. PubMed ID: 1656313
[TBL] [Abstract][Full Text] [Related]
27. The impact of progesterone receptor expression on relapse in the long-term clinical course of 93 benign meningiomas.
Strik HM; Strobelt I; Pietsch-Breitfeld B; Iglesias-Rozas JR; Will B; Meyermann R
In Vivo; 2002; 16(4):265-70. PubMed ID: 12224136
[TBL] [Abstract][Full Text] [Related]
28. Association between absence of epidermal growth factor receptor immunoreactivity and poor prognosis in patients with atypical meningioma.
Smith JS; Lal A; Harmon-Smith M; Bollen AW; McDermott MW
J Neurosurg; 2007 Jun; 106(6):1034-40. PubMed ID: 17564176
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical staining for claudin-1 can help distinguish meningiomas from histologic mimics.
Hahn HP; Bundock EA; Hornick JL
Am J Clin Pathol; 2006 Feb; 125(2):203-8. PubMed ID: 16393681
[TBL] [Abstract][Full Text] [Related]
30. Epidermal growth factor receptor overexpressed malignant fibrous histiocytoma associated with recurrent meningothelial meningioma.
Caltabiano R; Parisi G; Albanese V; Lanzafame S
Neurol Med Chir (Tokyo); 2009 Nov; 49(11):523-7. PubMed ID: 19940402
[TBL] [Abstract][Full Text] [Related]
31. The immunophenotypic spectrum of meningeal hemangiopericytoma: a comparison with fibrous meningioma and solitary fibrous tumor of meninges.
Perry A; Scheithauer BW; Nascimento AG
Am J Surg Pathol; 1997 Nov; 21(11):1354-60. PubMed ID: 9351573
[TBL] [Abstract][Full Text] [Related]
32. [Uridine diphosphate sugar in meningiomas of the brain].
Popova GM; Promyslov MSh; Gabibov GA
Zh Vopr Neirokhir Im N N Burdenko; 1996; (3):30-1. PubMed ID: 8975513
[TBL] [Abstract][Full Text] [Related]
33. Expression and structure of interleukin 4 receptors in primary meningeal tumors.
Puri S; Joshi BH; Sarkar C; Mahapatra AK; Hussain E; Sinha S
Cancer; 2005 May; 103(10):2132-42. PubMed ID: 15830341
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical evaluation of erbB-2 and p53 protein expression in benign and atypical human meningiomas.
Chozick BS; Benzil DL; Stopa EG; Pezzullo JC; Knuckey NW; Epstein MH; Finkelstein SD; Finch PW
J Neurooncol; 1996 Feb; 27(2):117-26. PubMed ID: 8699233
[TBL] [Abstract][Full Text] [Related]
35. The prognostic value of progesterone receptor status in meningiomas.
Roser F; Nakamura M; Bellinzona M; Rosahl SK; Ostertag H; Samii M
J Clin Pathol; 2004 Oct; 57(10):1033-7. PubMed ID: 15452155
[TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor, hepatocyte growth factor/scatter factor, basic fibroblast growth factor, and placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy.
Lamszus K; Lengler U; Schmidt NO; Stavrou D; Ergün S; Westphal M
Neurosurgery; 2000 Apr; 46(4):938-47; discussion 947-8. PubMed ID: 10764269
[TBL] [Abstract][Full Text] [Related]
37. Cytoplasmic iron deposition is associated with the expression of oxidative DNA damage marker in meningiomas.
Nagaishi M; Yokoo H; Osawa T; Nobusawa S; Tanaka Y; Ikota H; Yoshimoto Y; Nakazato Y
Neuropathology; 2013 Oct; 33(5):526-32. PubMed ID: 23406462
[TBL] [Abstract][Full Text] [Related]
38. Characterisation of oestrogen receptor, progesterone receptor, trefoil factor 1, and epidermal growth factor and its receptor in pancreatic cystic neoplasms and pancreatic ductal adenocarcinoma.
Yeh TS; Jan YY; Chiu CT; Ho YB; Chen TC; Lee KF; Chan KM; Hsu JC; Hwang TL; Chen MF
Gut; 2002 Nov; 51(5):712-6. PubMed ID: 12377812
[TBL] [Abstract][Full Text] [Related]
39. Prolactin receptors in human meningiomas: characterization and biological role.
Muccioli G; Ghè C; Faccani G; Lanotte M; Forni M; Ciccarelli E
J Endocrinol; 1997 Jun; 153(3):365-71. PubMed ID: 9203990
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical localization of c-erbB-2 protein and epidermal growth factor receptor in normal surface epithelium, surface inclusion cysts, and common epithelial tumours of the ovary.
Wang DP; Konishi I; Koshiyama M; Nanbu Y; Iwai T; Nonogaki H; Mori T; Fujii S
Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):393-400. PubMed ID: 1360720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
